Osaic Holdings’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $565K | Buy |
8,583
+318
| +4% | +$20.9K | ﹤0.01% | 2700 |
|
|
2025
Q1 | $584K | Sell |
8,265
-14,538
| -64% | -$1.03M | ﹤0.01% | 2724 |
|
|
2024
Q4 | $661K | Buy |
22,803
+16,371
| +255% | +$475K | ﹤0.01% | 2540 |
|
|
2024
Q3 | $454K | Sell |
6,432
-10,150
| -61% | -$717K | ﹤0.01% | 2963 |
|
|
2024
Q2 | $1.1M | Buy |
16,582
+194
| +1% | +$12.9K | ﹤0.01% | 2127 |
|
|
2024
Q1 | $1.11M | Buy |
16,388
+1,817
| +12% | +$123K | ﹤0.01% | 2234 |
|
|
2023
Q4 | $901K | Sell |
14,571
-23,595
| -62% | -$1.46M | ﹤0.01% | 2623 |
|
|
2023
Q3 | $2.25M | Buy |
38,166
+5,235
| +16% | +$309K | ﹤0.01% | 1890 |
|
|
2023
Q2 | $1.97M | Buy |
32,931
+231
| +0.7% | +$13.8K | ﹤0.01% | 1886 |
|
|
2023
Q1 | $1.91M | Buy |
32,700
+17,745
| +119% | +$1.04M | ﹤0.01% | 1858 |
|
|
2022
Q4 | $929K | Sell |
14,955
-1,113
| -7% | -$69.2K | ﹤0.01% | 2438 |
|
|
2022
Q3 | $908K | Sell |
16,068
-2,640
| -14% | -$149K | ﹤0.01% | 2330 |
|
|
2022
Q2 | $1.2M | Sell |
18,708
-8,616
| -32% | -$550K | ﹤0.01% | 2107 |
|
|
2022
Q1 | $16M | Buy |
27,324
+9,240
| +51% | +$5.41M | 0.03% | 532 |
|
|
2021
Q4 | $1.2M | Sell |
18,084
-26,448
| -59% | -$1.76M | ﹤0.01% | 2230 |
|
|
2021
Q3 | $2.72M | Buy |
44,532
+26,985
| +154% | +$1.65M | 0.01% | 1468 |
|
|
2021
Q2 | $1.09M | Sell |
17,547
-231
| -1% | -$14.3K | ﹤0.01% | 2282 |
|
|
2021
Q1 | $1.05M | Sell |
17,778
-2,082
| -10% | -$123K | ﹤0.01% | 2184 |
|
|
2020
Q4 | $1.19M | Sell |
19,860
-570
| -3% | -$34.1K | ﹤0.01% | 1885 |
|
|
2020
Q3 | $1.11M | Sell |
20,430
-4,785
| -19% | -$261K | ﹤0.01% | 1745 |
|
|
2020
Q2 | $1.29M | Buy |
25,215
+6,186
| +33% | +$317K | ﹤0.01% | 1555 |
|
|
2020
Q1 | $856K | Buy |
+19,029
| New | +$856K | ﹤0.01% | 1656 |
|